(2E)-1-(3-bromophenyl)-3-(2-methylphenyl)prop-2-en-1-one, 95.0%, 2g

(2S,4S)-4-(Diphenylphosphino)-2-[(diphenylphosphino)methyl]-N-phenyl-1-pyrrolidinecarboxamide, 98%, 1g

2,4,6-Trichlorophenyl Formate>97.0%(HPLC)1g

(R)-2-(4-Chloro-phenyl)-thiazolidine-4-carboxylic acid, 95.0%, 5g

2-(3-(Difluoromethyl)-4-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 250mg

3,4-Diaminopyridine, 98.0%, 1g

Benzyl (4-aminobicyclo[2.1.1]hexan-1-yl)carbamate, 98%, 1g

2-(4-((4-Chlorophenyl)ethynyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 5g

2-Iodo-4-(trifluoromethyl)benzonitrile, 97%, 100mg

4-Propionylbenzonitrile, 95%, 100mg

3-(Trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine hydrochloride, 98%, 500mg

2-Methyl-2-pentene>95.0%(GC)25mL

Eriocitrin, 98.78%, 1mg